APPENDIX I

ACCOUNTANTS’ REPORT

(b)

The Group entered into several foreign exchange forward contracts with banks in order to manage the
Group’s foreign currency exposure in relation to United States Dollar (“USD”) against RMB for its
planned operating funding transfer to a subsidiary in the United States. The major terms of these
contracts as at Track Record Period are as follows:

Notional amount

Maturity

Exchange rate

At December 31, 2016
Buy USD10,000,000
Buy USD3,500,000
Buy USD3,000,000
Buy USD15,000,000
Buy USD2,000,000
Buy USD18,000,000
Buy USD15,000,000

At December 31, 2017
Buy USD15,000,000
Buy USD2,000,000
Buy USD18,000,000

14/11/2017
14/11/2017
14/05/2018
15/05/2018
15/05/2018
16/05/2018
15/05/2018

15/05/2018
15/05/2018
16/05/2018

USD1/RMB6.9510
USD1/RMB6.9510
USD1/RMB6.9930
USD1/RMB7.0092
USD1/RMB7.0092
USD1/RMB7.0213
USD1/RMB7.0092

USD1/RMB7.0092
USD1/RMB7.0092
USD1/RMB7.0213

There was no outstanding foreign exchange forward contracts as at June 30, 2018.

(c)

(d)

(e)

In August 2013, the Group invested in a listed corporate bond which was traded publicly in Shanghai
Stock Exchange and was subsequently disposed in March 2018.

The Group entered into several contracts of funds (the “Fund”) with financial institutions. The principals
are not guaranteed and the return of the Fund are determined by reference to the performance of the
underlying instruments including equity and debt securities.

The Group invested in Hebei Boke Biotechnology Co., Ltd. (河北博科生物技術有限公司) (“Boke”) at
the fair value of RMB15,000,000 in April 2018, representing 5% of the registered capital of Boke. Boke
is mainly engaged in drug discovery and development consulting services.

24.

PLEDGED BANK DEPOSITS/BANK BALANCES AND CASH

The Group and the Company

The pledged bank deposits of the Group are pledged to banks for securing forward contracts (Note 23) with
interest rate of 1.10% to 1.75%. The pledged bank deposits are classified as non-current assets as at December 31,
2016 as the expected settlement date of the forward contract will be settled after twelve months from the end of the
reporting period. All pledged bank deposits were released as the corresponding forward contracts were matured
during the six months ended June 30, 2018.

Bank balances and cash of the Group comprised of cash, and short-term bank deposits with an original maturity
of three months or less. Bank balances carrying interest at market rates which ranged from 0.10% to 1.00% per annum
at December 31, 2016, from 0.10% to 1.00% per annum at December 31, 2017, and 0.30% to 1.00% per annum at
June 30, 2018.

– I-50 –

